DK3572090T5 - Korttidsvirkende faktor-vii-polypeptider - Google Patents

Korttidsvirkende faktor-vii-polypeptider Download PDF

Info

Publication number: DK3572090T5
Authority: DK; Denmark
Prior art keywords: short; acting factor; vii polypeptides; polypeptides; vii
Prior art date: 2012-12-24

Application number

DK19181784.0T

Other languages

English (en)

Other versions

DK3572090T3 (da

Inventor

Maxine Bauzon

Terry Hermiston

Original Assignee

Coagulant Therapeutics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-24

Filing date

2013-12-23

Publication date

2024-09-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51022016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3572090(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-23 Application filed by Coagulant Therapeutics Corp filed Critical Coagulant Therapeutics Corp

2023-01-09 Application granted granted Critical

2023-01-09 Publication of DK3572090T3 publication Critical patent/DK3572090T3/da

2024-09-02 Publication of DK3572090T5 publication Critical patent/DK3572090T5/da

Links

229940012413 factor vii Drugs 0.000 title 1
229920001184 polypeptide Polymers 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)

DK19181784.0T 2012-12-24 2013-12-23 Korttidsvirkende faktor-vii-polypeptider DK3572090T5 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261745674P	2012-12-24	2012-12-24
US201361787026P	2013-03-15	2013-03-15
EP13867801.6A EP2938351B8 (en)	2012-12-24	2013-12-23	Short-acting factor vii polypeptides

Publications (2)

Publication Number	Publication Date
DK3572090T3 DK3572090T3 (da)	2023-01-09
DK3572090T5 true DK3572090T5 (da)	2024-09-02

Family

ID=51022016

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK16196780.7T DK3165232T3 (da)	2012-12-24	2013-12-23	Faktor vii-polypeptider med kortvarig virkning
DK19181784.0T DK3572090T5 (da)	2012-12-24	2013-12-23	Korttidsvirkende faktor-vii-polypeptider
DK13867801.6T DK2938351T3 (da)	2012-12-24	2013-12-23	Faktor vii-polypeptider med kortvarig virkning

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK16196780.7T DK3165232T3 (da)	2012-12-24	2013-12-23	Faktor vii-polypeptider med kortvarig virkning

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK13867801.6T DK2938351T3 (da)	2012-12-24	2013-12-23	Faktor vii-polypeptider med kortvarig virkning

Country Status (21)

Country	Link
US (5)	US20150344863A1 (da)
EP (3)	EP3572090B1 (da)
JP (3)	JP6566869B2 (da)
KR (2)	KR102111934B1 (da)
CN (2)	CN105025913B (da)
AU (2)	AU2013370522B2 (da)
BR (1)	BR112015015182B1 (da)
CA (2)	CA3185756A1 (da)
DK (3)	DK3165232T3 (da)
ES (3)	ES2936485T3 (da)
HK (1)	HK1216855A1 (da)
IL (2)	IL239345B (da)
MX (3)	MX380585B (da)
NZ (1)	NZ708873A (da)
PE (2)	PE20151206A1 (da)
PL (3)	PL3572090T3 (da)
SA (1)	SA517380867B1 (da)
SG (2)	SG11201504986QA (da)
TW (3)	TWI681968B (da)
WO (1)	WO2014105784A1 (da)
ZA (1)	ZA201505315B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100267508B1 (ko)	1998-07-13	2001-01-15	김충섭	다겹지 제조용 접착제 및 이를 이용한 다겹지 제조방법
BR112015015182B1 (pt)	2012-12-24	2023-12-26	Coagulant Therapeutics Corporation	Variante polipeptídica isolada do fator vii, seu método de preparação e seu uso, e composições farmacêuticas e seus usos
TW201629215A (zh) *	2014-09-30	2016-08-16	拜耳保健有限責任公司	使用凝血酶之組成物及治療方法
KR101755838B1 (ko)	2015-09-09	2017-07-07	현대자동차주식회사	엔진 예열장치 및 그 예열방법
SG11201901989VA (en) *	2016-09-13	2019-04-29	Bayer Healthcare Llc	Factor viia glycoforms
KR102120921B1 (ko) *	2017-02-10	2020-06-10	주식회사 일리아스바이오로직스	Gba 단백질을 포함하는 엑소솜의 제조 방법 및 상기 제조 방법에 의해 제조된 엑소솜을 유효성분으로 함유하는 고셔병 예방 및 치료용 약학적 조성물
EP3833381B1 (en)	2019-08-15	2022-08-03	Catalyst Biosciences, Inc.	Modified factor vii polypeptides for subcutaneous administration

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3008252A (en)	1959-02-02	1961-11-14	Beatrice V Robinson	Puffed sleeve ironer
US5180583A (en)	1985-11-26	1993-01-19	Hedner Ulla K E	Method for the treatment of bleeding disorders
FR2632524B1 (fr) *	1988-06-09	1992-03-13	Fondation Nale Transfusion San	Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
CA2739933A1 (en)	2000-02-11	2001-08-16	Bayer Healthcare Llc	Factor vii or viia-like molecules
CA2409674C (en)	2000-05-23	2010-05-11	Neurologix, Inc.	Glutamic acid decarboxylase (gad) based delivery systems
US8008252B2 (en)	2001-10-10	2011-08-30	Novo Nordisk A/S	Factor VII: remodeling and glycoconjugation of Factor VII
US20050221335A1 (en)	2001-12-14	2005-10-06	Anthony Kavanagh	Reporter gene
WO2003093465A1 (en) *	2002-04-30	2003-11-13	Maxygen Holdings Ltd.	FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
US8512710B2 (en)	2002-11-22	2013-08-20	Ansun Biopharma, Inc.	Class of therapeutic protein based molecules
US7807174B2 (en)	2002-11-22	2010-10-05	Nexbio, Inc.	Class of therapeutic protein based molecules
CA2519873C (en) *	2003-03-20	2012-12-18	Maxygen Holdings Ltd.	Fvii or fviia variants
RU2373282C2 (ru) *	2003-06-19	2009-11-20	Байер Хелткэр Ллк	ВАРИАНТЫ ДОМЕНА GLA ФАКТОРА VII ИЛИ VIIa
US20060198819A1 (en) *	2003-08-08	2006-09-07	Novo Nordisk Healthcare A/G	Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
ES2381110T3 (es) *	2003-09-09	2012-05-23	Novo Nordisk Health Care Ag	Polipéptidos de factor VII de coagulación
CN103627670B (zh)	2004-02-13	2016-12-21	格莱克托普有限公司	高活性糖蛋白加工条件及其有效生产方法
BRPI0511046A (pt)	2004-05-10	2007-11-27	Basf Plant Science Gmbh	métodos para produzir uma construção de expressão múltipla, para produzir alimento ou produtos alimentìcios, produtos farmacêuticos ou produtos quìmicos, e uma planta ou célula de planta transgênica, construção de expressão múltipla, microorganismo,e, uso de um microorganismo, de uma célula de planta, de um tecido de planta, de um orgão de planta, ou de uma parte de uma planta
EP1761630A2 (en) *	2004-06-21	2007-03-14	Novo Nordisk Health Care AG	Glycosylation-disrupted factor vii variants
CN101137396A (zh)	2005-03-11	2008-03-05	弗雷泽纽斯卡比德国有限公司	由无活性初始材料制备生物活性糖蛋白
WO2006114105A2 (en) *	2005-04-26	2006-11-02	Maxygen Holdings Ltd.	Use of modified factor vii for treating bleeding
US20070129298A1 (en) *	2005-07-22	2007-06-07	Maxygen Holdings, Ltd.	In-solution activation of factor vii
US20070105755A1 (en)	2005-10-26	2007-05-10	Neose Technologies, Inc.	One pot desialylation and glycopegylation of therapeutic peptides
MX2008002395A (es) *	2005-08-19	2008-03-18	Neose Technologies Inc	Factor vii y factor viia glicopegilados.
WO2007054783A2 (en) *	2005-11-08	2007-05-18	Astellas Pharma Inc.	Compositions and methods for treating thrombocytopenia
NZ572418A (en) *	2006-05-05	2011-08-26	Millennium Pharm Inc	Factor xa inhibitors
FR2901707B1 (fr)	2006-05-31	2017-09-29	Lab Francais Du Fractionnement	Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
US7532621B2 (en)	2006-08-30	2009-05-12	Cornell Research Foundation, Inc.	Lateral error correction for time-critical multicast
PT2101821E (pt) *	2006-12-15	2014-10-03	Baxter Int	Fator conjugado viia-ácido (poli)siálico com prolongamento do tempo de meia vida in vivo
WO2008075787A1 (ja)	2006-12-20	2008-06-26	Sumitomo Chemical Company, Limited	偏光板および液晶表示装置
MX2009007139A (es)	2006-12-28	2009-10-08	Centocor Ortho Biotech Inc	Metodos y vectores para generar inmunoglobulinas no sialiladas.
CA2676686C (en)	2007-02-20	2015-12-15	Dsm Ip Assets B.V.	Novel sialidase
JP6050927B2 (ja)	2007-04-26	2016-12-21	シーエヌジェイホールディングス，インコーポレイテッド	高シアル酸含量を有する組換えビタミンｋ依存性タンパク質およびその調製方法
EP2930245B1 (en)	2007-10-12	2017-11-22	Sigma-Aldrich Co. LLC	Cell line and methods for improved glycoprotein sialylation
TWI465247B (zh) *	2008-04-11	2014-12-21	Catalyst Biosciences Inc	經修飾的因子ｖｉｉ多肽和其用途
US8557773B2 (en) *	2008-05-02	2013-10-15	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Treatment of bleeding with low half-life fibrinogen
JP2010022253A (ja) *	2008-07-17	2010-02-04	Kaneka Corp	アシアロ糖鎖化合物の作製方法
US9340769B2 (en)	2008-12-05	2016-05-17	The Regents Of The University Of California	Methods and compositions for treating P. acnes
US8400974B2 (en) *	2009-07-30	2013-03-19	Apple Inc.	Methods and apparatus for providing dynamic information in a wireless information channel
US20130196410A1 (en)	2010-03-05	2013-08-01	Alnylam Pharmaceuticals, Inc	Compositions and methods for modifying the glycosylation pattern of a polypeptide
WO2013017555A1 (en) *	2011-08-01	2013-02-07	Lfb-Biotechnologies	Factor vii compositions with specific glycosylation for controlled half-life
BR112015015182B1 (pt)	2012-12-24	2023-12-26	Coagulant Therapeutics Corporation	Variante polipeptídica isolada do fator vii, seu método de preparação e seu uso, e composições farmacêuticas e seus usos

2013
- 2013-12-23 BR BR112015015182-5A patent/BR112015015182B1/pt active IP Right Grant
- 2013-12-23 EP EP19181784.0A patent/EP3572090B1/en active Active
- 2013-12-23 PL PL19181784.0T patent/PL3572090T3/pl unknown
- 2013-12-23 ES ES19181784T patent/ES2936485T3/es active Active
- 2013-12-23 US US14/654,581 patent/US20150344863A1/en not_active Abandoned
- 2013-12-23 EP EP16196780.7A patent/EP3165232B1/en active Active
- 2013-12-23 EP EP13867801.6A patent/EP2938351B8/en active Active
- 2013-12-23 KR KR1020197017382A patent/KR102111934B1/ko active Active
- 2013-12-23 SG SG11201504986QA patent/SG11201504986QA/en unknown
- 2013-12-23 PL PL16196780T patent/PL3165232T3/pl unknown
- 2013-12-23 WO PCT/US2013/077405 patent/WO2014105784A1/en not_active Ceased
- 2013-12-23 CA CA3185756A patent/CA3185756A1/en active Pending
- 2013-12-23 CN CN201380073743.5A patent/CN105025913B/zh active Active
- 2013-12-23 JP JP2015549857A patent/JP6566869B2/ja active Active
- 2013-12-23 AU AU2013370522A patent/AU2013370522B2/en active Active
- 2013-12-23 PL PL13867801T patent/PL2938351T3/pl unknown
- 2013-12-23 DK DK16196780.7T patent/DK3165232T3/da active
- 2013-12-23 DK DK19181784.0T patent/DK3572090T5/da active
- 2013-12-23 HK HK16104910.1A patent/HK1216855A1/zh unknown
- 2013-12-23 SG SG10201710593UA patent/SG10201710593UA/en unknown
- 2013-12-23 KR KR1020157019457A patent/KR102047235B1/ko active Active
- 2013-12-23 DK DK13867801.6T patent/DK2938351T3/da active
- 2013-12-23 PE PE2015001020A patent/PE20151206A1/es unknown
- 2013-12-23 CA CA2896057A patent/CA2896057C/en active Active
- 2013-12-23 PE PE2020001539A patent/PE20211303A1/es unknown
- 2013-12-23 MX MX2015007712A patent/MX380585B/es unknown
- 2013-12-23 ES ES13867801T patent/ES2746116T3/es active Active
- 2013-12-23 CN CN201610960730.5A patent/CN107099522A/zh active Pending
- 2013-12-23 MX MX2016015101A patent/MX387579B/es unknown
- 2013-12-23 ES ES16196780T patent/ES2747726T3/es active Active
- 2013-12-23 NZ NZ70887313A patent/NZ708873A/en unknown
- 2013-12-24 TW TW102147863A patent/TWI681968B/zh active
- 2013-12-24 TW TW108130396A patent/TWI743542B/zh active
- 2013-12-24 TW TW108101456A patent/TWI708783B/zh active
2014
- 2014-07-25 US US14/341,359 patent/US10273466B2/en active Active
2015
- 2015-06-11 IL IL239345A patent/IL239345B/en active IP Right Grant
- 2015-06-16 MX MX2021002985A patent/MX2021002985A/es unknown
- 2015-06-23 SA SA517380867A patent/SA517380867B1/ar unknown
- 2015-07-23 ZA ZA2015/05315A patent/ZA201505315B/en unknown
2016
- 2016-09-14 US US15/265,703 patent/US10717970B2/en active Active
- 2016-10-28 JP JP2016211992A patent/JP6363677B2/ja active Active
2019
- 2019-04-16 AU AU2019202663A patent/AU2019202663B2/en active Active
- 2019-07-30 JP JP2019139775A patent/JP2019213540A/ja active Pending
2020
- 2020-03-24 IL IL273559A patent/IL273559B/en unknown
- 2020-06-09 US US16/896,646 patent/US11530401B2/en active Active
2022
- 2022-11-08 US US18/053,577 patent/US20230295596A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW201431876A (zh)	2014-08-16
EP2938351B8 (en)	2019-07-31
IL239345A0 (en)	2015-07-30
NZ749488A (en)	2021-09-24
US20210002624A1 (en)	2021-01-07
EP3165232B1 (en)	2019-07-10
JP2017071608A (ja)	2017-04-13
CN105025913A (zh)	2015-11-04
KR102047235B1 (ko)	2019-11-22
EP3572090A1 (en)	2019-11-27
CA2896057C (en)	2023-03-14
IL239345B (en)	2020-04-30
US20160376578A1 (en)	2016-12-29
AU2013370522B2 (en)	2019-01-17
TWI708783B (zh)	2020-11-01
US20150344863A1 (en)	2015-12-03
MX380585B (es)	2025-03-12
CN105025913B (zh)	2025-04-04
PL3572090T3 (pl)	2023-04-11
EP3165232A1 (en)	2017-05-10
CA3185756A1 (en)	2014-07-03
IL273559A (en)	2020-05-31
KR20150127573A (ko)	2015-11-17
JP2016507506A (ja)	2016-03-10
EP2938351A4 (en)	2016-08-24
MX387579B (es)	2025-03-18
KR102111934B1 (ko)	2020-05-18
MX2021002985A (es)	2021-05-14
TWI743542B (zh)	2021-10-21
MX2015007712A (es)	2015-09-07
DK3165232T3 (da)	2019-09-16
IL273559B (en)	2022-04-01
US20230295596A1 (en)	2023-09-21
PL3165232T3 (pl)	2019-12-31
BR112015015182B1 (pt)	2023-12-26
WO2014105784A1 (en)	2014-07-03
JP6363677B2 (ja)	2018-07-25
TWI681968B (zh)	2020-01-11
AU2019202663A1 (en)	2019-05-09
US11530401B2 (en)	2022-12-20
HK1216855A1 (zh)	2016-12-09
AU2019202663B2 (en)	2020-09-10
DK3572090T3 (da)	2023-01-09
PE20211303A1 (es)	2021-07-20
JP6566869B2 (ja)	2019-08-28
ES2747726T3 (es)	2020-03-11
PL2938351T3 (pl)	2020-03-31
TW202026309A (zh)	2020-07-16
US10717970B2 (en)	2020-07-21
SG11201504986QA (en)	2015-07-30
TW201920254A (zh)	2019-06-01
EP2938351A1 (en)	2015-11-04
SG10201710593UA (en)	2018-02-27
PE20151206A1 (es)	2015-09-04
BR112015015182A2 (pt)	2019-07-30
NZ708873A (en)	2019-11-29
JP2019213540A (ja)	2019-12-19
ES2936485T3 (es)	2023-03-17
DK2938351T3 (da)	2019-09-23
ES2746116T3 (es)	2020-03-04
AU2013370522A1 (en)	2015-07-09
KR20190072686A (ko)	2019-06-25
US20140363419A1 (en)	2014-12-11
EP2938351B1 (en)	2019-06-26
US10273466B2 (en)	2019-04-30
EP3572090B1 (en)	2022-12-14
CN107099522A (zh)	2017-08-29
AU2013370522A2 (en)	2016-10-06
ZA201505315B (en)	2022-11-30
SA517380867B1 (ar)	2020-06-10
CA2896057A1 (en)	2014-07-03

Publication	Publication Date	Title
PT2878018T (pt)	2018-02-22	Resumo
PT2819623T (pt)	2018-01-19	Resumo
EP2763896A4 (en)	2015-03-11	UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da)	2021-02-22	Polymercoatings
EP2880683A4 (en)	2016-03-30	BVA INTERPOSER
DK2825087T3 (da)	2019-05-13	Otoscanner
EP2809145A4 (en)	2015-09-16	CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da)	2020-09-14	Ikke-disruptiv-gen-targetering
EP2814472A4 (en)	2015-11-04	DITHIOAMINE REDUCING AGENTS
DK2873977T3 (da)	2020-06-08	Dobbeltdækker-rørdispenser
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
DK2854722T3 (da)	2020-08-24	Stomipose
PT2674413T (pt)	2017-09-18	Resumo
EP2941099A4 (en)	2016-08-24	SWITCHING DEVICE
PT2831109T (pt)	2018-02-07	Resumo
PT2825212T (pt)	2018-03-14	Resumo
EP2831482A4 (en)	2015-12-16	Flange gasket
EP2816694A4 (en)	2015-10-28	FLAT CABLE WINDING DEVICE
DK2825157T3 (da)	2019-01-02	Aminosyrelipider
EP2809729A4 (en)	2015-09-02	Siloxane polyether copolymers
EP2862179A4 (en)	2016-06-01	FUEL CURRENT INSPECTION PROBE
EP2869113A4 (en)	2015-12-02	DISPLAY DEVICE FOR VEHICLE
DE112012006214T8 (de)	2015-04-16	Wulstringwickler
DK2831122T3 (da)	2016-05-17	Anthocyanidin-kompleks
DK3572090T3 (da)	2023-01-09	Korttidsvirkende faktor-vii-polypeptider